Intervention Review

Injection allergen immunotherapy for asthma

  1. Michael J Abramson1,*,
  2. Robert M Puy2,
  3. John M Weiner3

Editorial Group: Cochrane Airways Group

Published Online: 4 AUG 2010

Assessed as up-to-date: 11 APR 2009

DOI: 10.1002/14651858.CD001186.pub2


How to Cite

Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database of Systematic Reviews 2010, Issue 8. Art. No.: CD001186. DOI: 10.1002/14651858.CD001186.pub2.

Author Information

  1. 1

    Monash University, Epidemiology & Preventive Medicine, Melbourne, Victoria, Australia

  2. 2

    The Alfred, Department of Allergy, Immunology & Respiratory Medicine, Melbourne, Vic, Australia

  3. 3

    AllergyNet Australia, Melbourne, Australia

*Michael J Abramson, Epidemiology & Preventive Medicine, Monash University, School of Public Health & Preventive Medicine, The Alfred, Melbourne, Victoria, 3004, Australia. Michael.Abramson@monash.edu. michael.abramson@med.monash.edu.au.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 4 AUG 2010

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Elizabeth C. Matsui, Peyton A. Eggleston, Pediatric Allergy: Principles and Practice, 2016,

    CrossRef

  2. 2
    N. Santos, A.M. Pereira, R. Silva, J. Torres da Costa, J.L. Plácido, Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010, Allergologia et Immunopathologia, 2015, 43, 1, 25

    CrossRef

  3. 3
    Ritesh Agarwal, AshutoshNath Aggarwal, Digambar Behera, Thanagakunam Balamugesh, Sahajal Dhooria, Ashish Bhalla, Dhruva Chaudhry, SunilK Chhabra, Ramesh Chokhani, Vishal Chopra, DevendraS Dadhwal, George D′Souza, SurinderK Jindal, Dheeraj Gupta, Mandeep Garg, ShailendraN Gaur, Bharat Gopal, AlokeG Ghoshal, Randeep Guleria, KrishnaB Gupta, Indranil Haldar, Sanjay Jain, NirmalK Jain, VikramK Jain, AshokK Janmeja, Surya Kant, Surender Kashyap, GopiC Khilnani, VenkataN Maturu, InderpaulS Sehgal, Valliappan Muthu, KuruswamyT Prasad, LakshmikantB Yenge, Navneet Singh, Jai Kishan, Raj Kumar, ParvaizA Koul, Ashok Mahashur, AmitK Mandal, Samir Malhotra, Sabir Mohammed, PrasantaR Mohapatra, Dharmesh Patel, Rajendra Prasad, Pallab Ray, JaiK Samaria, PotsangbamSarat Singh, Honey Sawhney, Nusrat Shafiq, Navneet Sharma, Updesh PalS Sidhu, Rupak Singla, JagdishC Suri, Deepak Talwar, Subhash Varma, Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations, Lung India, 2015, 32, 5, 3

    CrossRef

  4. 4
    Raj Kumar, Nitesh Gupta, Indu Bisht, Inflammatory response to subcutaneous allergen-specific immunotherapy in patients with bronchial asthma and allergic rhinitis, Indian Journal of Allergy, Asthma and Immunology, 2015, 29, 1, 7

    CrossRef

  5. 5
    Timothy P. Moran, A. Wesley Burks, Is Clinical Tolerance Possible after Allergen Immunotherapy?, Current Allergy and Asthma Reports, 2015, 15, 5

    CrossRef

  6. 6
    S. Gomez-André, L’immunothérapie allergénique : les méta-analyses, mise au point en 2015, Revue Française d'Allergologie, 2015, 55, 3, 189

    CrossRef

  7. 7
    Esozia Arroabarren, Ana I. Tabar, Susana Echechipía, Koldo Cambra, Blanca E. García, Maria J. Alvarez-Puebla, Optimal duration of allergen immunotherapy in children with dust mite respiratory allergy, Pediatric Allergy and Immunology, 2015, 26, 1
  8. You have free access to this content8
    N. G. Papadopoulos, J. A. Bernstein, P. Demoly, M. Dykewicz, W. Fokkens, P. W. Hellings, A. T. Peters, C. Rondon, A. Togias, L. S. Cox, Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report, Allergy, 2015, 70, 5
  9. 9
    C. Begne, A Didier, Quelle place pour la désensibilisation?, Revue des Maladies Respiratoires Actualités, 2015, 7, 2, 172

    CrossRef

  10. 10
    Lianqin Tao, Baoyu Shi, Guochao Shi, Huanying Wan, Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trials, The Clinical Respiratory Journal, 2014, 8, 2
  11. 11
    Sameer K. Mathur, Ravi K. Viswanathan, Relevance of Allergy in Adult Asthma, Current Allergy and Asthma Reports, 2014, 14, 5

    CrossRef

  12. 12
    Harold S. Nelson, Subcutaneous Immunotherapy Versus Sublingual Immunotherapy: Which Is More Effective?, The Journal of Allergy and Clinical Immunology: In Practice, 2014, 2, 2, 144

    CrossRef

  13. 13
    Tomokazu Matsuoka, Mohamed H Shamji, Stephen R Durham, Allergen Immunotherapy and Tolerance, Allergology International, 2013, 62, 4, 403

    CrossRef

  14. 14
    Jocelyne Just, Atopy is important in the management of asthma, Paediatric Respiratory Reviews, 2013, 14, 2, 92

    CrossRef

  15. 15
    C. Mailhol, A. Didier, Immunothérapie allergénique dans le traitement de l’allergie aux pollens, Revue des Maladies Respiratoires, 2013, 30, 2, 142

    CrossRef

  16. 16
    Jennifer A. Kannan, Tolly G. Epstein, Immunotherapy Safety: What Have We Learned from Surveillance Surveys?, Current Allergy and Asthma Reports, 2013, 13, 4, 381

    CrossRef

  17. 17
    Kenny Y. Kwong, Sydney Leibel, Update on Allergen Immunotherapy for Treatment of Allergic Diseases, Advances in Pediatrics, 2013, 60, 1, 141

    CrossRef

  18. 18
    L. Moral, Are we prescribing too much or too little immunotherapy for children with allergic rhinitis?, Allergologia et Immunopathologia, 2012, 40, 3, 135

    CrossRef

  19. 19
    Ariana Murata, Patrick M. Ling, Asthma Diagnosis and Management, Emergency Medicine Clinics of North America, 2012, 30, 2, 203

    CrossRef

  20. 20
    Sarah K. Wise, Rodney J. Schlosser, Evidence-Based Practice, Otolaryngologic Clinics of North America, 2012, 45, 5, 1045

    CrossRef

  21. 21
    Robert K. Bush, Cheri Swenson, Beth Fahlberg, Michael D. Evans, Robert Esch, William W. Busse, House dust mite sublingual immunotherapy: Results of a US trial, Journal of Allergy and Clinical Immunology, 2011, 127, 4, 974

    CrossRef

  22. 22
    Y. Martinat, B. Wallaert, A. Didier, A. Seferian, Immunothérapie jusqu’à quel âge ?, Revue des Maladies Respiratoires Actualités, 2011, 3, 3, 198

    CrossRef

  23. 23
    Moisés A. Calderón, Robert J. Boyle, Martin Penagos, Aziz Sheikh, Immunotherapy: The Meta-Analyses. What have we Learned?, Immunology and Allergy Clinics of North America, 2011, 31, 2, 159

    CrossRef

  24. 24
    Harold S. Nelson, Some highlights of the first century of immunotherapy, Annals of Allergy, Asthma & Immunology, 2011, 107, 5, 417

    CrossRef

  25. 25
    Harold S. Nelson, Subcutaneous Injection Immunotherapy for Optimal Effectiveness, Immunology and Allergy Clinics of North America, 2011, 31, 2, 211

    CrossRef

  26. 26
    S. Radulovic, D. Wilson, M. Calderon, S. Durham, Systematic reviews of sublingual immunotherapy (SLIT), Allergy, 2011, 66, 6
  27. 27
    David I. Bernstein, Tolly Epstein, Systemic Reactions to Subcutaneous Allergen Immunotherapy, Immunology and Allergy Clinics of North America, 2011, 31, 2, 241

    CrossRef

  28. 28
    Christopher C. Copenhaver, Anne Parker, Steven Patch, Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice, Annals of Allergy, Asthma & Immunology, 2011, 107, 5, 441

    CrossRef

  29. 29
    J. Flabbée, Traitement symptomatique des maladies allergiques respiratoires et oculaires, EMC - Traité de médecine AKOS, 2011, 6, 3, 1

    CrossRef

  30. You have free access to this content30
    The Cochrane Database of Systematic Reviews – Issue 8 of 2010, Journal of Evidence-Based Medicine, 2010, 3, 3
  31. 31
    Melina Makatsori, Stephen Durham, Moises A Calderon, Specific immunotherapy for latex allergy, The Cochrane Library,